An implant that treats patient pain following knee surgery for up to three weeks relies on biodegradable polymers from Evonik to expand drug-delivery window.
Funds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels Vivasure Medical ("Vivasure" or the "Company"), a company pioneering